Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleDIPG-25. GENETIC ALTERATIONS TARGETING THE MAPK PATHWAY CONFERS PRECLINICAL SENSITIVITY TO TRAMETINIB IN A CO-CLINICAL TRIAL IN DIPG.AuthorsIzquierdo, Elisa; Carvalho, Diana; Boult, Jessica; Mackay, Alan; Temelso, Sara; Molinari, Valeria; Stubbs, Mark; Burke, Rosemary; Depani, Sarita; O'Hare, Patricia; Robinson, Simon; Hubank, Michael; Hargrave, Darren; Jones, ChrisPublicationNeuro-Oncology, 2019, Vol 21, pii74ISSN1522-8517Publication typeArticleDOI10.1093/neuonc/noz036.046